Remtolumab (ABT-122) is a dual-variable domain immunoglobulin specifically engineered to neutralize tumor necrosis factor ?? (TNF??) and interleukin-17A (IL-17A). This biologic exhibits potent dual inhibition, effectively targeting both cytokines implicated in inflammatory processes. It is particularly useful in research focused on rheumatoid arthritis (RA), providing a valuable tool for investigating the pathophysiology and potential therapeutic interventions for this condition.
Remtolumab (ABT-122) is a dual-variable domain immunoglobulin specifically engineered to neutralize tumor necrosis factor ?? (TNF??) and interleukin-17A (IL-17A). This biologic exhibits potent dual inhibition, effectively targeting both cytokines implicated in inflammatory processes. It is particularly useful in research focused on rheumatoid arthritis (RA), providing a valuable tool for investigating the pathophysiology and potential therapeutic interventions for this condition.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
